Clinical trial
Ultra-low-dose Coronary Artery Calcium Scoring: Evaluation of Prognostic Performance and Impact of Physiological Factors on Quantification in a Large Population
NCT03637231 is registered in ClinicalTrials.gov with University of Zurich as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ultra-low-dose Coronary Artery Calcium Scoring: Evaluation of Prognostic Performance and Impact of Physiological Factors on Quantification in a Large Population
- Lead sponsor
- University of Zurich
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- July 5, 2018
- Completion date
- October 25, 2021
- Enrollment
- 301 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.